Meet Qlife Holding’s CFO Kasper Rousøe who will present their Q1 report. The company publishes the report on the same day as the event takes place.
The event takes place on the 26th. of May from 12:00 – 12:30 CEST. After the presentation, you are more than welcome to ask questions.
Qlife Holding AB is a med-tech group that strives to revolutionize the market for clinical biomarkers and virus tests. By enabling tests at home as a complement to tests in healthcare, access to important health information is facilitated, which can contribute to better treatment and potentially prevent diseases.Qlife Holding was formed in October 2019 and received the certification ISO 13485:2016 the same year, which means that Qlife meets all requirements for manufacturing and selling in-vitro diagnostic analyzers and reagents. The first capsules in the company's product, Egoo.Health Platform, were CE-marked for professional use in early 2020. The company has patent protection for key parts of its technology.Qlife Holding AB is listed on Nasdaq First North Stockholm with the ticker QLIFE.
Disclaimer: HC Andersen Capital receives payment from Qlife Holding for a DigitalIR/Corporate Visibility agreement./Claus Thestrup 15.47 17 MAY.